HSIC vs JUNS · P/E 24, rev $6.83B vs rev $21.8K
Henry Schein Inc (HSIC) versus Jupiter Neurosciences, Inc. Common Stock (JUNS) — a side-by-side from cached financials, not a winner call.
Henry Schein Inc (HSIC) is a medical distribution company listed on NASDAQ.
Jupiter Neurosciences, Inc. Common Stock (JUNS) is a biotechnology company listed on NASDAQ.
Latest reported HSIC revenue for 2026-06-27 was $6.83B. Net income was $201.0M. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
Latest reported JUNS revenue for 2025-12-31 was $21.8K. Net income was -$8.6M. JUNS currently screens at market cap $10.0M.
HSIC currently screens at market cap $9.11B and trailing P/E 24.2. JUNS currently screens at market cap $10.0M.
Not investment advice. Open the HSIC and JUNS stock pages for the full models.
Not investment advice.